KYMR vs. XBI
Compare and contrast key facts about Kymera Therapeutics, Inc. (KYMR) and SPDR S&P Biotech ETF (XBI).
XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: KYMR or XBI.
Correlation
The correlation between KYMR and XBI is 0.63, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
KYMR vs. XBI - Performance Comparison
Key characteristics
KYMR:
-0.05
XBI:
-0.01
KYMR:
0.36
XBI:
0.15
KYMR:
1.04
XBI:
1.02
KYMR:
-0.05
XBI:
-0.01
KYMR:
-0.18
XBI:
-0.03
KYMR:
17.04%
XBI:
9.40%
KYMR:
58.59%
XBI:
24.39%
KYMR:
-87.51%
XBI:
-63.89%
KYMR:
-57.39%
XBI:
-46.61%
Returns By Period
In the year-to-date period, KYMR achieves a -6.98% return, which is significantly lower than XBI's 2.95% return.
KYMR
-6.98%
-14.37%
-18.39%
-3.23%
N/A
N/A
XBI
2.95%
2.44%
-7.39%
0.41%
-0.87%
2.79%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
KYMR vs. XBI — Risk-Adjusted Performance Rank
KYMR
XBI
KYMR vs. XBI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Kymera Therapeutics, Inc. (KYMR) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
KYMR vs. XBI - Dividend Comparison
KYMR has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.14%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KYMR Kymera Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XBI SPDR S&P Biotech ETF | 0.14% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% |
Drawdowns
KYMR vs. XBI - Drawdown Comparison
The maximum KYMR drawdown since its inception was -87.51%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for KYMR and XBI. For additional features, visit the drawdowns tool.
Volatility
KYMR vs. XBI - Volatility Comparison
Kymera Therapeutics, Inc. (KYMR) has a higher volatility of 12.79% compared to SPDR S&P Biotech ETF (XBI) at 5.62%. This indicates that KYMR's price experiences larger fluctuations and is considered to be riskier than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.